Tuesday, November 10, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Hims & Hers to offer unapproved peptides after US eases curbs

Nov 9 (Reuters) - Hims & Hers Health said on Monday it will begin offering some unapproved peptide treatments in November after US regulators eased curbs, with plans to later…

DO
By Daniel Okafor · Regulatory Correspondent
Nov 9 16:15 ETSource: Bellingham Herald

From the source

Hims & Hers to offer unapproved peptides after US eases curbs

Nov 9 (Reuters) - Hims & Hers Health said on Monday it will begin offering some unapproved peptide treatments in November after US regulators eased curbs, with plans to later expand into compounded versions of BPC-157 and TB-500, popular wellness products that also lack FDA approval.

Read at bellinghamherald.com
PeptiPrescribed peptides from $99/moSee all →